- Home
- BODI vs DXR Comparison
BODI vs DXR Comparison
Compare BODI & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- DXR
- Stock Information
- Founded
- BODI 1998
- DXR 1970
- Country
- BODI United States
- DXR United States
- Employees
- BODI N/A
- DXR N/A
- Industry
- BODI Industrial Machinery/Components
- DXR Medical/Dental Instruments
- Sector
- BODI Industrials
- DXR Health Care
- Exchange
- BODI Nasdaq
- DXR Nasdaq
- Market Cap
- BODI 40.1M
- DXR 46.9M
- IPO Year
- BODI N/A
- DXR N/A
- Fundamental
- Price
- BODI $6.80
- DXR $11.42
- Analyst Decision
- BODI Buy
- DXR Strong Buy
- Analyst Count
- BODI 2
- DXR 1
- Target Price
- BODI $10.00
- DXR $25.00
- AVG Volume (30 Days)
- BODI 14.7K
- DXR 6.8K
- Earning Date
- BODI 11-11-2025
- DXR 01-01-0001
- Dividend Yield
- BODI N/A
- DXR N/A
- EPS Growth
- BODI N/A
- DXR 3.46
- EPS
- BODI N/A
- DXR 0.36
- Revenue
- BODI $324,871,000.00
- DXR $66,306.00
- Revenue This Year
- BODI N/A
- DXR N/A
- Revenue Next Year
- BODI N/A
- DXR N/A
- P/E Ratio
- BODI N/A
- DXR $31.70
- Revenue Growth
- BODI N/A
- DXR N/A
- 52 Week Low
- BODI $3.38
- DXR $6.55
- 52 Week High
- BODI $8.71
- DXR $11.70
- Technical
- Relative Strength Index (RSI)
- BODI 67.83
- DXR 56.80
- Support Level
- BODI $5.30
- DXR $11.37
- Resistance Level
- BODI $7.29
- DXR $11.70
- Average True Range (ATR)
- BODI 0.47
- DXR 0.49
- MACD
- BODI 0.10
- DXR -0.00
- Stochastic Oscillator
- BODI 77.42
- DXR 83.53
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.